AbbVie Inc (ABBV)
NYSE
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current ABBV market cap is 326.78B. The company's latest EPS is USD 2.4219 and P/E is 76.59.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 12.31B | 14.46B | 14.46B | 15.11B | 13.34B |
| Operating Income | 2.8B | 4B | 3.83B | -1.49B | 3.73B |
| Net Income | 1.37B | 1.37B | 1.56B | -22M | 1.29B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 45.8B | 56.2B | 58.05B | 54.5B | 56.34B |
| Operating Income | 11.36B | 17.92B | 18.12B | 12.76B | 9.14B |
| Net Income | 4.62B | 11.54B | 11.84B | 4.86B | 4.28B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 148.87B | 141.94B | 143.42B | 135.16B | 136.17B |
| Total Liabilities | 140.83B | 135.12B | 137.35B | 131.8B | 134.7B |
| Total Equity | 8.05B | 6.82B | 6.07B | 3.36B | 1.46B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 150.57B | 146.53B | 138.81B | 134.71B | 135.16B |
| Total Liabilities | 137.47B | 131.09B | 121.52B | 124.31B | 131.8B |
| Total Equity | 13.1B | 15.44B | 17.29B | 10.4B | 3.36B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 4.04B | 6.31B | 11.76B | 18.81B | 1.64B |
| Investing | -9.59B | -10.69B | -18.95B | -20.82B | -735M |
| Financing | 10.82B | 4.72B | 1.65B | -5.21B | -1.26B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 17.59B | 22.78B | 24.94B | 22.84B | 18.81B |
| Investing | -37.56B | -2.34B | -623M | -2.01B | -20.82B |
| Financing | -11.5B | -19.04B | -24.8B | -17.22B | -5.21B |
| Market Cap | 326.78B |
| Price to Earnings Ratio | 76.59 |
| Price to Sales Ratio | 5.82 |
| Price to Cash Ratio | 59.31 |
| Price to Book Ratio | 97.4 |
| Dividend Yield | 3.55% |
| Shares Outstanding | 1.77B |
| Average Volume (1 week) | 4.72M |
| Average Volume (1 Month) | 5.02M |
| 52 Week Change | 8.45% |
| 52 Week High | 218.66 |
| 52 Week Low | 163.52 |
| Spread (Intraday) | 2.5 (1.34%) |
| Company Name | AbbVie Inc |
| Address |
1521 concord pike suite 201 wilmington, delaware 19803 |
| Website | https://www.abbvie.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
